Biodegradable intravitreal tyrosine kinase implants
US9233070B2 · kind B2 · utility
3Cited by
139References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2013 |
| Grant date | Jan 12, 2016 |
| Priority date | — |
| Expiry date | Aug 19, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants can be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.